Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host

被引:237
作者
Ganapathy, Vadivel [1 ]
Thangaraju, Muthusamy [1 ]
Prasad, Puttur D. [1 ]
Martin, Pamela M. [1 ]
Singh, Nagendra [1 ]
机构
[1] Georgia Regents Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30904 USA
关键词
PROTEIN-COUPLED RECEPTOR; TUMOR-SUPPRESSOR; NICOTINIC-ACID; PUMA-G; INFLAMMATORY RESPONSES; SLC5A8; BUTYRATE; HEALTH; FERMENTATION; RELEVANCE;
D O I
10.1016/j.coph.2013.08.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mutually beneficial relationship between colonic bacteria and the host has been recognized but the molecular aspects of the relationship remain poorly understood. Dietary fiber is critical to this relationship. The short-chain fatty acids acetate, propionate and butyrate, generated by bacterial fermentation of dietary fiber, serve as messengers between colonic bacteria and the host. The beneficial effects of these bacterial metabolites in colon include, but are not limited to, suppression of inflammation and prevention of cancer. Recent studies have identified the plasma membrane transporter SLC5A8 and the cell-surface receptors GPR109A and GPR43 as essential for the biologic effects of short-chain fatty acids in colon. These three proteins coded by the host genome provide the molecular link between colonic bacteria and the host.
引用
收藏
页码:869 / 874
页数:6
相关论文
共 45 条
[1]  
[Anonymous], 1997, FOOD NUTR PREVENTION
[2]  
[Anonymous], 2011, SCIENCE, V334, P1629
[3]   Prebiotics, probiotics and digestive health [J].
Balakrishnan, Maya ;
Floch, Martin H. .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2012, 15 (06) :580-585
[4]   GPR43/FFA2: physiopathological relevance and therapeutic prospects [J].
Bindels, Laure B. ;
Dewulf, Evelyne M. ;
Delzenne, Nathalie M. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (04) :226-232
[5]  
Blad CC, 2011, ADV PHARMACOL, V62, P219, DOI 10.1016/B978-0-12-385952-5.00005-1
[6]   Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics? [J].
Chen, James S. ;
Faller, Douglas V. ;
Spanjaard, Remco A. .
CURRENT CANCER DRUG TARGETS, 2003, 3 (03) :219-236
[7]   APPLICATIONS OF NEXT-GENERATION SEQUENCING The human microbiome: at the interface of health and disease [J].
Cho, Ilseung ;
Blaser, Martin J. .
NATURE REVIEWS GENETICS, 2012, 13 (04) :260-270
[8]   The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter [J].
Coady, MJ ;
Chang, MH ;
Charron, FA ;
Plata, C ;
Wallendorff, B ;
Sah, JF ;
Markowitz, SD ;
Romero, ME ;
Lapointe, JY .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 557 (03) :719-731
[9]   The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function [J].
Coothankandaswamy, Veena ;
Elangovan, Selvakumar ;
Singh, Nagendra ;
Prasad, Puttur D. ;
Thangaraju, Muthusamy ;
Ganapathy, Vadivel .
BIOCHEMICAL JOURNAL, 2013, 450 :169-178
[10]  
Cresci G, 2013, J PARENTER ENTERAL N